IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v17y2020i4p1230-d320573.html
   My bibliography  Save this article

Serum Sclerostin But Not DKK-1 Correlated with Central Arterial Stiffness in End Stage Renal Disease Patients

Author

Listed:
  • Chun-Feng Wu

    (Division of Metabolism and Endocrinology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi 62247, Taiwan
    These authors contributed equally to this work.)

  • Jia-Sian Hou

    (Division of Nephrology, Buddhist Tzu-Chi General Hospital, Hualien 97004, Taiwan
    These authors contributed equally to this work.)

  • Chih-Hsien Wang

    (Division of Nephrology, Buddhist Tzu-Chi General Hospital, Hualien 97004, Taiwan)

  • Yu-Li Lin

    (Division of Nephrology, Buddhist Tzu-Chi General Hospital, Hualien 97004, Taiwan
    School of Medicine, Tzu-Chi University, Hualien 97004, Taiwan)

  • Yu-Hsien Lai

    (Division of Nephrology, Buddhist Tzu-Chi General Hospital, Hualien 97004, Taiwan)

  • Chiu-Huang Kuo

    (Division of Nephrology, Buddhist Tzu-Chi General Hospital, Hualien 97004, Taiwan)

  • Hung-Hsiang Liou

    (Division of Nephrology, Department of Medicine, Hsin-Jen Hospital, New Taipei City 24243, Taiwan)

  • Jen-Pi Tsai

    (School of Medicine, Tzu-Chi University, Hualien 97004, Taiwan
    Division of Nephrology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi 62247, Taiwan)

  • Bang-Gee Hsu

    (Division of Nephrology, Buddhist Tzu-Chi General Hospital, Hualien 97004, Taiwan
    School of Medicine, Tzu-Chi University, Hualien 97004, Taiwan)

Abstract

Sclerostin and dickkopf-1 (DKK1) played a role in the development of cardiovascular diseases and arterial stiffness in chronic kidney disease (CKD) patients but with controversial results of patients in end-stage renal disease (ESRD) including hemodialysis (HD) and peritoneal dialysis (PD). This study aimed to examine the association between the mode of dialysis or the values of sclerostin or DKK1 and carotid-femoral pulse wave velocity (cfPWV) in ESRD patients. There were 122 HD and 72 PD patients enrolled in this study. By a validated tonometry system, cfPWV was measured and then segregated patients into values of >10 m/s as the high central arterial stiffness (AS) group and values ≤ 10 m/s as the control group. Serum levels of sclerostin and DKK1 were measured using a commercial enzyme-linked immunosorbent assay kit. Possible risk factors for the development of AS were analyzed by logistic regression analysis. There were 21 (29.2%) of PD and 53 (43.4%) of HD in the high AS group. Compared to patients in the control group, those in the high AS group were older, had more comorbidities, had higher systolic blood pressure, and had higher serum levels of fasting glucose, C-reactive protein, and sclerostin. Levels of sclerostin (adjusted OR 1.012, 95% CI. 1.006–1.017, p = 0.0001) was found to be an independent predictor of high AS in ESRD patients by multivariate logistic regression analysis. Furthermore, receiver operating characteristic curve analysis showed the optimal cut-off values of sclerostin for predicting AS was 208.64 pmol/L (Area under the curve 0.673, 95% CI: 0.603–0.739, p < 0.001). This study showed that serum levels of sclerostin, but not DKK1 or mode of dialysis, to be a predictor for high central AS in ESRD patients.

Suggested Citation

  • Chun-Feng Wu & Jia-Sian Hou & Chih-Hsien Wang & Yu-Li Lin & Yu-Hsien Lai & Chiu-Huang Kuo & Hung-Hsiang Liou & Jen-Pi Tsai & Bang-Gee Hsu, 2020. "Serum Sclerostin But Not DKK-1 Correlated with Central Arterial Stiffness in End Stage Renal Disease Patients," IJERPH, MDPI, vol. 17(4), pages 1-13, February.
  • Handle: RePEc:gam:jijerp:v:17:y:2020:i:4:p:1230-:d:320573
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/17/4/1230/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/17/4/1230/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:4:p:1230-:d:320573. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.